SPY316.11-0.94 -0.30%
DIA261.17-1.83 -0.70%
IXIC10,440.07+6.42 0.06%

Eyenovia Reports Resumed Recruitment Of Phase 3 CHAPERONE Study For Progressive Myopia

Benzinga · -